Aims The objective of this study is to ascertain whether an early three‐month treatment with electrotherapy and biofeedback restores continence in urinary incontinence patients after radical prostatectomy (RP). Methods Design: The study performed a randomized, controlled trial of parallel and open groups. Configuration: Secondary care, urology department of a university hospital complex. Participants: Patients sent for RP due to prostate cancer (n = 60), 47 patients finally completed the study. Interventions: The treatment group (TG) received physiotherapy consisting of electrotherapy and biofeedback, 3 days a week for 3 months, while the control group (CG) received no specific treatment. Both groups received a guide to perform pelvic floor exercises at home. The measurement instruments used were the 1‐ and 24‐hour pad tests and the International Consultation on Incontinence Questionnaire Short‐Form. The recording method used was a micturition (urinary) diary. Results The results of the 1‐hour pad test (PT) show statistically significant differences between groups at 3 months (P = .001) and 6 months (P = .001), in favor of those in the TG. Sixty‐four percent of patients in the TG recovered continence as against 9.1% in the CG after 3 months in the 1‐hour PT, in line with the objective of this study. Conclusions An early physiotherapy program helps RP patients with urinary incontinence recover continence after 3 months. Moreover, they lead a better quality life.

No abstract

No abstract

RESUMEN"ADENOCARCINOMA MUCINOSO DE URACO" OBJETIVO: El adenocarcinoma de uraco es un tumor extremadamente raro, con una incidencia de 1/5.000.000 de habitantes, lo que representa menos del 0,001 de todos los tumores de vejiga.CASO CLÍNICO: Varón de 51 años con historia de dolor suprapúbico y hematuria. La exploración física y la urografía intravenosa eran normales. La cistoscopia demostraba un área edematosa en la cúpula de la vejiga. La biopsia transuretral confirmó un adenocarcinoma moderadamente diferenciado, con anticuerpos positivos CK7 y CK20. El antígeno carcinoembrionario era de 6,6. Se practicó cistectomía parcial extensa, seguida de quimioterapia y radioterapia.CONCLUSIONES: El tratamiento del adenocarcinoma de uraco con una combinación de cistectomía parcial extensa, quimioterapia y radioterapia es eficaz.PALABRAS CLAVE: Uraco. Carcinoma. Tumores de vejiga. ABSTRACT"MUCINOUS ADENOCARCINOMA OF THE URACHUS" OBJETIVE: The Adenocarcinoma of the Urachus is very rare tumor, with an incidence of 1/5.000.000 inhabitants, represents less than 0.001 of all types of bladder cancer.CASE REPORT: A 51 year old man with a chronic history of suprapubic pain and hematuria. Physical examination and excretory urography were normal. The cistoscopy demostrated a oedematosa area in cupola of bladder wall. The transuretral biopsy was moderately differentiated adenocarcinoma, with positive antibody to CK7 and CK20. the carcinoembryonic antigen was 6.6 ng/ml. Extended partial cystectomy was done, followed for chemotherapy and radiotherapy.CONCLUSIONS: The treatment of adenocarcinoma of the urachus with a combination of extended partial cystectomy, chemotherapy and radiation, is a efective treatment. Actas Urol Esp. 27 (2). [142][143][144][145][146] 2003 142 N NO OT TA A C CL LÍ ÍN NI IC CA A E l uraco es el remanente embriológico del alantoides obliterado. Es una estructura fibrosa extraperitoneal que discurre por la línea media, desde la cúpula vesical y el ombligo, entre la lámi-na posterior de la vaina de los rectos por delante y la pared del peritoneo por detrás.La mayoría de los carcinomas de uraco son adenocarcinomas 1 . Son tumores muy poco frecuentes, con una incidencia de 1 caso anual por cada 5.000.000 de habitantes, lo que representa el 0,001 de todos los cánceres de vejiga 2-4 . La incidencia es más alta en los varones que en las mujeres, con una relación de 4/1 5,6 .Las manifestaciones clínicas del carcinoma de uraco suelen ser las derivadas de la invasión por el tumor de las estructuras vecinas. El síntoma más

No abstract